Power Law company profile

Surface Oncology

Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2018 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$18M

Market cap · 2026

Revenue

$30M

Latest reported FY

Investors

5 investors on Surface Oncology's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 2 investors entered at this stage

Series A 3 investors entered at this stage

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo